Powder: -20°C for 3 years | In solvent: -80°C for 2 years
(±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. Later studies determined that 15-LO from rabbit reticulocytes and human monocytes were able to metabolize cholesteryl linoleate, a major component of LDL, to 13-HODE cholesteryl ester.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry |
Description | (±)13-HODE cholesteryl ester was originally extracted from atherosclerotic lesions and shown to be produced by Cu2+-catalyzed oxidation of LDL. Later studies determined that 15-LO from rabbit reticulocytes and human monocytes were able to metabolize cholesteryl linoleate, a major component of LDL, to 13-HODE cholesteryl ester. |
Molecular Weight | 665.1 |
Formula | C45H76O3 |
CAS No. | 167354-91-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Ethanol:PBS (1:10): <10 μg/mL
DMF: >50 mg/mL
DMSO: >50 mg/mL
Ethanol: >50 mg/mL
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)13-HODE cholesteryl ester 167354-91-8 (±)13HODE cholesteryl ester (±)13 HODE cholesteryl ester inhibitor inhibit